Roxadustat for renal patients with hyporesponsiveness to ESAs: a new opportunity?
- PMID: 34148177
- DOI: 10.1007/s11739-021-02794-w
Roxadustat for renal patients with hyporesponsiveness to ESAs: a new opportunity?
Comment on
-
Roxadustat for dialysis patients with erythropoietin hypo-responsiveness: a single-center, prospective investigation.Intern Emerg Med. 2021 Nov;16(8):2193-2199. doi: 10.1007/s11739-021-02738-4. Epub 2021 May 22. Intern Emerg Med. 2021. PMID: 34021853
References
Reference
-
- KDOQI (2006) Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47(Suppl 3):S11–S145
-
- Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA (2019) Treatment of anemia with darbepoetin prior to dialysis initiation and clinical outcomes: analyses from the trial to reduce cardiovascular events with aranesp therapy (TREAT). Am J Kidney Dis 73:309–315 - DOI
-
- Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD (2003) Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 42:761–773 - DOI
-
- Koulouridis I, Alfayez M, Trikalinos TA, Balk EM, Jaber BL (2013) Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a meta-regression analysis. Am J Kidney Dis 61:44–56 - DOI
-
- Chen N, Hao C, Peng X, Lin H, Yin A, Hao L, Tao Y, Liang X, Liu Z, Xing C, Chen J, Luo L, Zuo L, Liao Y, Liu BC, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP (2019) Roxadustat for anemia in patients with kidney disease not receiving dialysis. N Engl J Med 381:1001–1010 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
